Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.
Anti-inflammatory genes associated with multiple sclerosis: A gene expression study.
A Standardized, Evidence-Based Massage Therapy Program for Decentralized Elite Paracyclists: Creating the Model.
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation.
Comparison of Point Estimates and Average Thicknesses of Retinal Layers Measured Using Manual Optical Coherence Tomography Segmentation for Quantification of Retinal Neurodegeneration in Multiple Sclerosis.
Care of patients with multiple sclerosis.
Teva targets $4 billion lupus market with laquinimod study
Fingolimod Therapy and Macular Hemorrhage.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis.
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.
Assisted reproduction technology in multiple sclerosis: Giving birth to a new avenue of research in hormones and autoimmunity.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions.
Gain of glycosylation: A new pathomechanism of myelin protein zero mutations.
Inflammation high-field magnetic resonance imaging.
Persistence of Epstein-Barr Virus in Self-reactive Memory B Cells.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Myelin Basic Protein synthesis is regulated by small non-coding RNA 715.
Antibodies to potassium channels in multiple sclerosis.
Pages
« first
‹ previous
…
269
270
271
272
273
274
275
276
277
…
next ›
last »